Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
ROUNDTABLE HEALTHCARE PARTNERS MAKES INVESTMENT IN DEERLAND ENZYMES & PROBIOTICS
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Enzymes & Probiotics (“Deerland” or the “Company”).
June 22, 2017
1 Min Read
.png?width=850&auto=webp&quality=95&format=jpg&disable=upscale "ROUNDTABLE HEALTHCARE PARTNERS MAKES INVESTMENT IN DEERLAND ENZYMES & PROBIOTICS")
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made an investment in Deerland Enzymes & Probiotics (“Deerland” or the “Company”).
You May Also Like
Recommended
Sponsored Content
May 1, 2024
.png?width=800&auto=webp&quality=80&disable=upscale)